Arkolith/Insider Trading/HUMA/Form 4

Sander Dale A.

CFO and Chief Corp. Deve. Off.Humacyte, Inc. (HUMA) · full profile →Form 4 · filed Aug 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$263K
Net Open-Market Flow
-$263K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2024Sell(S)39K$6.68$263K2K
Aug 27, 2024Option exercise(M)39K$2.56$101K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 27, 2024Option exercise(M)39K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000165) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML